Abstract:Cardiovascular disease continues to be a leading cause of death in the United States. A major underlying cause of cardiovascular events such as stroke and myocardial infarction is atherosclerosis. Notable mediators in the pathogenesis of atherosclerosis include vascular smooth muscle cells (VSMCs) and inflammation. During atherogenesis, the SMCs undergo phenotypic change from a quiescent state to a synthetic, proliferative state. The synthetic SMCs drive neointima formation which influences the stenosis characteristic of atherosclerosis. Signaling of a receptor tyrosine kinase called EphA2 has been previously determined to have a role in SMC phenotypic change. It was found that a global and SMC specific knockdown (KD) of EphA2 resulted in decreased plaque formation, suggesting the role of EphA2 expression in promoting SMC proliferation. Inflammation is another important factor that contributes to plaque formation. Oxidized low-density lipoproteins (LDLs) have been found to also cause VSMCs to undergo change to a synthetic phenotype, one that resembles macrophages. Cytokines released by macrophages orchestrate the pro-inflammatory response that affects the development and stability of atherosclerotic plaques. Considering the important role inflammation also serves in the progression of plaque formation, we investigated the relationship between EphA2 and VSMC-mediated inflammatory response. Cre-flox breeding was performed to achieve EphA2 knockout (KO) specifically in VSMCs of 8-10-wk old ApoE -/- mice. Successful KO was confirmed with PCR and Western blot. Si-RNA was transfected to achieve KD in human SMCs. The cells were then treated with cytokines, including IL-1 beta, TNF-alpha, IL-6, IL-33, and interferon-gamma, followed by RT-qPCR analysis to measure expression of inflammatory genes. To assess cytokine secretion, we utilized a cytokine array to measure presence of the cytokines of interest. Protein analysis to quantify expression of inflammatory proteins in KO vs control cells was done via Western blot. We observed that the loss of EphA2 causes significant reductions in the production of several proinflammatory cytokines and chemokines, indicating its role in mediating VSMC inflammatory responses.

Sm22 Alpha Inhibits Vascular Inflammation Via Stabilization Of I Kappa B Alpha In Vascular Smooth Muscle Cells

Sm22 Alpha Suppresses Cytokine- Induced Inflammation And The Transcription Of Nf-Kappa B Inducing Kinase (Nik) By Modulating Srf Transcriptional Activity In Vascular Smooth Muscle Cells

SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells.

Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology

SMOC2 promoted vascular smooth muscle cell proliferation, migration, and extracellular matrix degradation by activating BMP/TGF-I31

Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis

SM22α Modulates Vascular Smooth Muscle Cells Phenotype Through Bundling F‐actin

SM22α Loss Contributes to Apoptosis of Vascular Smooth Muscle Cells Via Macrophage-Derived Circrasgef1b.

Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid

The Role of SM22α in Vascular Smooth Muscle Cells

Abstract 3131: An Investigation Into The Interplay Between Epha2 And Inflammatory Responses In Vascular Smooth Muscle Cells

Mir-22-3p Inhibits Arterial Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia by Targeting HMGB1 in Arteriosclerosis Obliterans.

miR‐141‐5p suppresses vascular smooth muscle cell inflammation, proliferation, and migration via inhibiting the HMGB1/NF‐κB pathway

Tnf-Alpha Suppresses Prolyl-4-Hydroxylase Alpha 1 Expression Via the Ask1-Jnk-Nono Pathway

Effect of NF-κB on Inflammation and Apoptosis of Rat Vascular Smooth Muscle Cells

Tissue Factor Pathway Inhibitor-2 is Downregulated by Ox-Ldl and Inhibits Ox-Ldl Induced Vascular Smooth Muscle Cells Proliferation and Migration

Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell Via Akt/mTOR Signaling.

WITHDRAWN: Smooth Muscle Cell-Specific Knockout of Interferon Gamma (Ifn-Γ) Receptor Attenuates Intimal Hyperplasia Via STAT1-KLF4 Activation

Tanshinone IIA inhibits VSMC inflammation and proliferation in vivo and in vitro by downregulating miR-712-5p expression

Effects Of Cytokines On The Expression Of Angiotensin Ii Type 1 Receptors In Vascular Smooth Muscle Cells

Dual Regulation of Tumor Necrosis Factor-Α on Myosin Light Chain Phosphorylation in Vascular Smooth Muscle